Quantcast

Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference

By GlobeNewswire,  December 07, 2017, 04:05:00 PM EDT


YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller will present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare ConferenceDecember 14, 2017, at 9 am ET in New York. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A replay of the webcast will be available for 90 days following the conclusion of the event.

About Optinose®

Optinose is a specialty pharmaceutical company on a mission to improve lives with a focus on patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has corporate offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com.

Optinose Media Contact

Kate Traynor, Sloane & Company

Ktraynor@sloanepr.com

212.446.1871

Optinose Investor Contact

Jonathan Neely

Jonathan.neely@optinose.com

973.722.4356

Source: OptiNose, Inc.

This article appears in: News Headlines

Referenced Stocks: OPTN


Latest News Video









Today's Market Activity

NASDAQ 6936.58
80.05  ▲  1.17%
DJIA 24651.74
143.08  ▲  0.58%
S&P 500 2675.81
23.80  ▲  0.90%
Data as of Dec 15, 2017